127
Participants
Start Date
November 21, 2017
Primary Completion Date
March 7, 2019
Study Completion Date
March 7, 2019
Omalizumab
Participants received omalizumab as a subcutaneous injection once every 2 weeks (q2w) or once every 4 weeks (q4w). The dose (from 75 mg up to 600 mg) and dosing frequency (q2w or q4w) was determined by serum total IgE level and body weight using the study-drug dosing table.
Placebo
Participants received matching placebo as a subcutaneous injection once every 2 weeks or once every 4 weeks. The dose and dosing frequency was determined by serum total IgE level and body weight using the study-drug dosing table.
Bajcsy-Zsilinszky Korhaz es Rendelointezet, Budapest
Szent Imre Egyetemi Oktatokorhaz, Budapest
Szent Janos Korhaz es Eszak-Budai Egyesitett Korhazak, Budapest
UZ Leuven, Leuven
Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Kar, Pécs
UZ Gent, Ghent
Hospital de Jerez, Jerez de la Frontera
CHUS - H. Clinico U. de Santiago; Servicio de Otorrinonaringologia, Santiago de Compostela
Institute for Asthma & Allergy, Chevy Chase
Chesapeake Clinical Research Inc - CRN, Baltimore
Eastern Virginia Medical School, Norfolk
Hospital Universitario Fundacion Jimenez Diaz., Madrid
Unidad de Investigacion CIMA SC, Chihuahua City
Specialist Global Research, Hialeah
Centre Hospitalier Universitaire de Bordeaux Hopital Pellegrin, Bordeaux
Terveystalo Tampere, Tampere
University of South Florida, Tampa
Clinical Research Center of Alabama, LLC, Birmingham
Hospital Universitario Virgen Macarena, Seville
Ternopil Municipal City Hospital, Ternopil
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
University of Missouri, ENT and Allergy Center of Missouri, Columbia
University of Kansas Medical Center, Kansas City
Hopital de Hautepierre, Strasbourg
Nouvel Hopital Civil; Pole de Pathologie Thoracique, Strasbourg
"Municipal Institution City Clinical Hospital #3", Zaporizhzhia
TTS Research, Boerne
Allergy & Asthma Res Ctr PA, San Antonio
Colorado ENT & Allergy, Colorado Springs
Banner University of Arizona Medical Center, Tucson
Bensch Clinical Research LLC, Stockton
Kaiser Permanente - Rancho Cordova Medical Offices, Rancho Cordova
Allergy Associates Research Center LLC - CRN, Portland
Central Clinical Hospital With Polyclinic of President Administration of RF, Moscow
LLC Kurator, Saint Petersburg
Medical Center Uromed, Smolensk
Brigham and Womens Hospital, Boston
Synexus - Katowice, Katowice
Centrum Medyczne Wos i Piwowarczyk, Krakow
Centrum Alergologii Specjalistyczna Przychodnia Alergologiczna, Lublin
Synexus - Warsaw, Warsaw
Centrum Medyczne Biotamed, Wieliczka
EMC Instytut Medyczny S.A., Wroclaw
Hospital Clinic de Barcelona, Barcelona
SI Institute of Otolaryngology n.a. Prof. O.S. Kolomiychenko, Kyiv
Hoffmann-La Roche
INDUSTRY